NM_000260.4:c.5856+50G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000260.4(MYO7A):​c.5856+50G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,327,794 control chromosomes in the GnomAD database, including 208,644 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24124 hom., cov: 32)
Exomes 𝑓: 0.56 ( 184520 hom. )

Consequence

MYO7A
NM_000260.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.743

Publications

11 publications found
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
MYO7A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
  • Usher syndrome type 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant nonsyndromic hearing loss 11
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Usher syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-77207452-G-A is Benign according to our data. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-77207452-G-A is described in CliVar as Benign. Clinvar id is 255664.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO7ANM_000260.4 linkc.5856+50G>A intron_variant Intron 42 of 48 ENST00000409709.9 NP_000251.3 Q13402-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO7AENST00000409709.9 linkc.5856+50G>A intron_variant Intron 42 of 48 1 NM_000260.4 ENSP00000386331.3 Q13402-1
MYO7AENST00000458637.6 linkc.5742+50G>A intron_variant Intron 42 of 48 1 ENSP00000392185.2 Q13402-2
MYO7AENST00000409619.6 linkc.5709+50G>A intron_variant Intron 43 of 49 1 ENSP00000386635.2 Q13402-8
MYO7AENST00000458169.2 linkc.3282+50G>A intron_variant Intron 22 of 28 1 ENSP00000417017.2 H7C4D8
MYO7AENST00000670577.1 linkn.*454+50G>A intron_variant Intron 25 of 31 ENSP00000499323.1 A0A590UJ94

Frequencies

GnomAD3 genomes
AF:
0.561
AC:
85176
AN:
151872
Hom.:
24084
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.540
Gnomad AMI
AF:
0.603
Gnomad AMR
AF:
0.620
Gnomad ASJ
AF:
0.528
Gnomad EAS
AF:
0.483
Gnomad SAS
AF:
0.395
Gnomad FIN
AF:
0.649
Gnomad MID
AF:
0.608
Gnomad NFE
AF:
0.564
Gnomad OTH
AF:
0.576
GnomAD2 exomes
AF:
0.561
AC:
95601
AN:
170476
AF XY:
0.550
show subpopulations
Gnomad AFR exome
AF:
0.529
Gnomad AMR exome
AF:
0.670
Gnomad ASJ exome
AF:
0.524
Gnomad EAS exome
AF:
0.507
Gnomad FIN exome
AF:
0.650
Gnomad NFE exome
AF:
0.567
Gnomad OTH exome
AF:
0.557
GnomAD4 exome
AF:
0.558
AC:
655674
AN:
1175804
Hom.:
184520
Cov.:
16
AF XY:
0.552
AC XY:
326654
AN XY:
591464
show subpopulations
African (AFR)
AF:
0.539
AC:
14620
AN:
27134
American (AMR)
AF:
0.664
AC:
24086
AN:
36258
Ashkenazi Jewish (ASJ)
AF:
0.521
AC:
12412
AN:
23828
East Asian (EAS)
AF:
0.480
AC:
16951
AN:
35304
South Asian (SAS)
AF:
0.413
AC:
30983
AN:
74936
European-Finnish (FIN)
AF:
0.649
AC:
32320
AN:
49804
Middle Eastern (MID)
AF:
0.575
AC:
3028
AN:
5266
European-Non Finnish (NFE)
AF:
0.565
AC:
493346
AN:
872440
Other (OTH)
AF:
0.549
AC:
27928
AN:
50834
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
14378
28756
43135
57513
71891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12598
25196
37794
50392
62990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.561
AC:
85277
AN:
151990
Hom.:
24124
Cov.:
32
AF XY:
0.563
AC XY:
41799
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.541
AC:
22412
AN:
41452
American (AMR)
AF:
0.621
AC:
9489
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.528
AC:
1834
AN:
3472
East Asian (EAS)
AF:
0.484
AC:
2477
AN:
5120
South Asian (SAS)
AF:
0.395
AC:
1902
AN:
4810
European-Finnish (FIN)
AF:
0.649
AC:
6873
AN:
10582
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.564
AC:
38352
AN:
67964
Other (OTH)
AF:
0.575
AC:
1212
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1929
3858
5788
7717
9646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.564
Hom.:
4470
Bravo
AF:
0.562
Asia WGS
AF:
0.437
AC:
1521
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 2 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 11 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.9
DANN
Benign
0.41
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276290; hg19: chr11-76918497; COSMIC: COSV68683308; COSMIC: COSV68683308; API